Healthcare
M&A Advisory
Pharmaceutical
Marketing
M&A Advisory
Lazard
Full Credential Description
Shire Plc. United Kingdom, United States. Announced Date 17/01/2014. Closed Date 17/01/2014. Deal value: $300m. Shire to divest DERMAGRAFT®. Industry: Shire Plc was a biopharmaceutical company focused on developing and marketing innovative medicines for rare diseases and other specialized conditions.